Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 37,128 shares at $22.64 ($804K) on 2020-05-13, disclosed to the SEC on 2020-05-15.
Open-market sale of $804k COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.92 | 1,380 | $29K | 3.6% |
| 2 | $21.21 | 11,969 | $254K | 31.6% |
| 3 | $21.21 | 11,969 | $254K | 31.6% |
| 4 | $22.64 | 5,905 | $134K | 16.6% |
| 5 | $22.64 | 5,905 | $134K | 16.6% |
| Total | $21.65 avg | 37,128 |
| $804K |
| 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |